Posts

Colon Cancer Alliance Announces Corporate Name Change

National Non-Profit Begins A New Chapter Revealing New Name, New Logo, & Inclusive Mission

November 2, 2017 (Washington, D.C.) –  Effective immediately, the Colon Cancer Alliance is now the Colorectal Cancer Alliance, embracing the entire colorectal cancer community, adopting a new name, and committing to a powerful mission: To empower a nation of allies who work with us to provide support for patients and families, caregivers, and survivors; to raise awareness of preventative measures; and inspire efforts to fund critical research. The official rebrand brings an inclusive identity that ensures accuracy, leadership, and most important- alliance within the colorectal cancer community.

The Launch of a Nation of Allies – The name change is part of a larger rebranding effort for the organization which includes a new logo and visual identity, new website, and commitment to accuracy for the entire colorectal cancer community.

With the strategic mission of servicing both colon and rectal cancer patients, combined with fierce determination to end colorectal cancer within our lifetime, the Colorectal Cancer Alliance set three ambitious goals:  

  • Double the number of patients served by 2021
  • Save 100,000 lives with preventive screening in the next 10 years
  • Invest $10 million in critical research

The organization launched nationofallies.org a national network for advocates and allies to show their support in eliminating colorectal cancer within our lifetime and highlight ways individuals can educate their local communities on prevention and screening options. The focus of the “Nation of Allies” theme is to empower individuals to work with the Colorectal Cancer Alliance to provide support to patients and families, survivors, and caregivers, to raise awareness of preventative measures, and to inspire efforts to fund critical research.

“On behalf of the entire Colorectal Cancer Alliance community, we are beyond thrilled to be launching this new name, logo and visual identity to help continue to grow as the leading resource for patients and families,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance.  The Colorectal Cancer Alliance is the oldest, largest colorectal cancer non-profit in the nation and I am proud to part of this amazing evolution” Michael Sapienza, CEO, Colorectal Cancer Alliance.

Nearly a third of all colorectal cancers diagnosed this year will be rectal cancer. Nearly 40,000 new U.S. cases of rectal cancer will be diagnosed in 2017 alone. Colon cancer and rectal cancer are often grouped together because they have a lot in common—including symptoms—but they are different, depending on where they originate. Through this rebrand, the Colorectal Cancer Alliance has extended its reach into the colorectal cancer community by 30% while committing to align a nation of allies, together in the mission to end this disease.

“We share a common goal of eradicating colorectal cancer through prevention and early detection,” said Kevin Conroy, chairman and CEO of Exact Sciences and long time national partner of the Colorectal Cancer Alliance. “As this new chapter begins for the Colorectal Cancer Alliance, we are committed to working together to increase awareness about the importance of getting screened for this preventable disease.”

The name change and brand reveal debuted alongside the 2017 Tomorrow Can’t Wait National Conference at the Cleveland Clinic on November 1st. Conference attendees consisting of patients, survivors, and caregivers, had front row seats and true VIP access at the Rock & Roll Hall of Fame for the official kick-off. The nonprofit decided on the Rock & Roll Hall of Fame from so many requests from cancer patients attending the conference. You can visit the Facebook live rebrand announcement at tomorrowcantwait.org.

“To be surrounded by patients and families at such a historic event, celebrating new beginnings and amazing accomplishments is truly one of the most important nights of my life. We are grateful to this nation of allies supporting our vision: A world free of colorectal cancer within our lifetime” Michael Sapienza, CEO.

The Colorectal Cancer Alliance worked with Alexandria, VA based creative agency Grafik on the new identity and overall rebranding efforts.

To learn more about the rebrand and Colorectal Cancer Alliance, visit nationofallies.org.

 

About the Colorectal Cancer Alliance

The Colorectal Cancer Alliance is a national nonprofit committed to ending colorectal cancer. Working with our nation of passionate allies, we diligently support the needs of patients and families, caregivers, and survivors, eagerly raise awareness of preventative screening, and continually strive to fund critical research. As allies in the struggle, we are fiercely determined to end colorectal cancer within our lifetime. For more information, visit nationofallies.org.

Statement from Michael Sapienza, CEO of the Colon Cancer Alliance, on FDA Approval of VARUBI Intravenous Administration

October 26, 2017 (WASHINGTON) – VARUBI, a highly anticipated treatment for colorectal patients who suffer from delayed chemotherapy-induced nausea, has been approved by the Food and Drug Administration for delivery via one-time intravenous administration. This new way to administer VARUBI provides healthcare providers with flexibility to treat patients in a more individualized manner.

VARUBI addresses delayed nausea that can arrive 24 to 120 hours after the start of chemotherapy. If nausea is not managed aggressively, it can lead to weight loss, dehydration, and hospitalization. Quality-of-life issues are incredibly important for patients and families dealing with colorectal cancer and chemotherapy. The approval of VARUBI is good step forward in addresses some of these concerns.

For more information about VARUBI, please access: https://globenewswire.com/news-release/2017/10/25/1153687/0/en/TESARO-Announces-U-S-FDA-Approval-of-VARUBI-IV-for-Delayed-Nausea-and-Vomiting-Associated-With-Cancer-Chemotherapy.html

Statement on Blue Hope Nation

New opportunities are around every corner. In the past, Colon Cancer Alliance has partnered with different organizations to collaborate in online communities with the goal of assisting as many patients and families as possible. However, in order to end this disease in our lifetime, and to truly make “blue the new pink” we need ONE united voice.

Effective today, Blue Hope Nation, the largest colorectal cancer online support group, will be the exclusive online community. With double the engagement of any other online colorectal cancer community, along with the expertise of certified patient & family navigators managing communication, Blue Hope Nation is the best place to find hope, support, and answers.

One of our strategic goals is to double the number of patients we serve over the next five years by pouring more resources into improving how we connect with families, patients and caregivers like you. We’re doubling down on providing the best support possible, through initiatives like our one on one Buddy Program, expert webinars, live chats with certified patient navigators, access to real-time clinical trials through our Clinical Trial Finder, and more. Blue Hope Nation is the ideal resource to learn about these initiatives and how they impact your life for the better.

We are proud to serve more than 1.5 million patients and families every year and we will continue to do everything we can for this community. We are an organization saving lives through prevention and cancer research.

We’d like to acknowledge Erika Brown for the work she’s done with the online community, Colontown. The Colon Cancer Alliance and Chris4Life helped support and develop Colontown and we’re proud of where they’ve come and wish them the best.

I invite you to join in our mission and participate in Blue Hope Nation and be part of the largest colorectal cancer movement out there.

Building communities and creating a safe, supportive environment is key to the success of the colorectal cancer journey. We’re so happy to be part of your journey and look forward to connecting with you in Blue Hope Nation.

P.S. We’ve listened to the Colorectal Cancer Community… Big news is coming this fall… Stay tuned for exciting updates!

Colon Cancer Alliance Launches First-Ever Chris4Life Peer-Reviewed Research Program

First Grant to Respond to the Rising Trends in Young-Onset Colorectal Cancer by Awarding Multi-Year Grant to a Qualified Researcher

Washington, DC — The Colon Cancer Alliance is pleased to launch its first-ever Chris4Life Peer-Reviewed research program. The program is titled the Chris4Life Peer Reviewed research program, named in honor of Colon Cancer Alliance’s Founder & CEO’s mother Christine Sapienza who passed away from colon cancer in 2009. Given the rising trends in young-onset colorectal cancer and the recent data released in the Journal of the National Cancer Institute, which indicates that adults born in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared with those born in 1950, this grant cycle will offer opportunities for young-onset colorectal cancer research.

“The Colon Cancer Alliance is dedicated to investing $10 million in life-saving research by 2021,” said CEO Michael Sapienza.  “Through our peer-reviewed research program, our agenda will include understanding why those under 50 are increasingly diagnosed with colorectal cancer and decreasing late-state diagnosis of high-risk populations, advancing precision medicine and immunotherapies and developing better mechanisms for pre-disease and early diagnosis of colorectal cancer. By funding research in these critical areas, we hope to be one step closer to a future free of colon cancer,” Sapienza added.  

The grant selection process will utilize a research proposal review system similar to that of the National Institutes of Health. Research proposals will be reviewed by members of a distinguished Scientific Review Panel. Members of the panel are drawn from outstanding institutions such as:

      • National Cancer Institute
      • M.D. Anderson Cancer Center
      • Fox Chase Cancer Center
      • Georgetown University Lombardi Cancer Center
      • Hofstra-Northwell School of Medicine
      • University of Colorado
      • University of South Carolina

The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and should focus on changes in the microbiome and its impact in the development of young onset colorectal cancer. The underlying goal of the Colon Cancer Alliance’s research program is to provide funding for innovative projects expected to lead to future funding from other peer-reviewed sources.

A multi-year grant in the amount of $125,000 will be awarded at the end of the year, with grant terms to begin January 2, 2018.  Interested investigators can find further details at www.ccalliance.org/get-information/research/apply-research-grant/.   Applications must be submitted no later than 11:59 PM EDT, Thursday, August 31, 2017, using the Colon Cancer Alliance’s on-line application.  Additional inquires may be directed to Stephanie Guiffre at sguiffre@ccalliance.org.

# # #

The Colon Cancer Alliance is a national nonprofit committed to ending colon cancer within our lifetime. Working with our nation of passionate advocates, we are empowered to support the needs of patients and survivors, eager to raise awareness of preventative screening, and poised to help fund critical research. We are fiercely determined to end colon cancer once and for all. www.ccalliance.org

 

Special thanks to Olympus, The Lyons Family and Roanne’s Race for their support of our Research program.